Tag: Phase

London, Uk, Jan. 18, 2024 (GLOBE NEWSWIRE) -- As Phase 3 of the Pandoshi (PAMBO) presale rapidly approached the 80% ...

XHANCE significantly reduced both symptoms and sinus opacification in participants with chronic sinusitis (chronic rhinosinusitis) in two randomized controlled Phase ...

The trial now progresses into its second part, expected to complete later in 2024. ALK to submit a protocol amendment ...

Cleared First Four Monotherapy Doses and Initial Combination Cohort with No Dose Limiting Toxicities at any Dose Level KVA12123 Monotherapy ...

First enrollment and first subject dosing expected soon at Erasmus Medical Center in Rotterdam, Netherlands Management discusses the announcement and ...

Company to host Conference Call and live Webcast on Sunday, January 7, 2024 at 5:30 pm PT. An executive summary ...

KYN-5356 is an innovative, first-in-class small molecule that targets KAT-II, a key enzyme in the kynurenine pathway Topline results are ...

ORION CORPORATION PRESS RELEASE 27 DECEMBER 2023 at 11:00 EET                      NEJM Evidence publishes results from Phase I/IIa CYPIDES trial with ODM-208 ...

 Investigational Review Board (IRB) approval has been granted for 60 Degrees Pharma’s double-blind, placebo-controlled study to investigate tafenoquine for treatment ...

SAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the ...